EE/NE

DRUG2 trials

Sponsors

GlaxoSmithKline, Otsuka Pharmaceutical Development & Commercialization, Inc.

Conditions

Healthy VolunteersInfections, Bacterial

Phase 1

A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women

WithdrawnNCT01953809

GlaxoSmithKlineInfections, Bacterial

Start: 2014-08-31End: 2015-03-31Updated: 2015-01-28

A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together

RecruitingNCT07446400

Otsuka Pharmaceutical Development & Commercialization, Inc.Healthy Volunteers

Start: 2026-03-31End: 2026-11-07Target: 48Updated: 2026-08-12